Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07106996Phase 1Recruiting
Phase 1, open-label, single-arm trial, sponsored by Sichuan Provincial People's Hospital. Primary endpoints: Interleukin-18 at 6 months, Interleukin-1 beta at 6 months and 10 more. Started Jul 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07106996.